Mechanistically, JWA blocks integrin αvβ3-ILK and MMP2 signaling pathways by degrading SP1 via ubiquitination modifications, thus inhibiting the metastasis and angiogenesis of melanoma and gastric cancer, respectively [26,27,28]. Here, ARL6IP5 is linked to gastric cancer.